Metagenomic analysis of the interaction between the gut microbiota and colorectal cancer: a paired-sample study based on the GMrepo database

被引:4
|
作者
Chen, Han [1 ,2 ]
Jiao, Jianhua [1 ,2 ]
Wei, Min [3 ]
Jiang, Xingzhou [1 ,2 ]
Yang, Ruoyun [1 ,2 ]
Yu, Xin [1 ,2 ]
Zhang, Guoxin [1 ,2 ]
Zhou, Xiaoying [1 ,2 ]
机构
[1] First Affiliated Hosp Nanjing Med, Dept Gastroenterol, Univ 300 Guangzhou Rd, Nanjing 210029, Peoples R China
[2] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Peoples R China
[3] Nanjing Jiangning Hosp, Dept Gastroenterol, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Gut microbiota; Metagenomic analysis; Matched case-control study; GMrepo Database; AKKERMANSIA-MUCINIPHILA; CELLS;
D O I
10.1186/s13099-022-00527-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Previous evidence has shown that the gut microbiota plays a role in the development and progression of colorectal cancer (CRC). This study aimed to provide quantitative analysis and visualization of the interaction between the gut microbiota and CRC in order to establish a more precise microbiota panel for CRC diagnosis. Method: A paired-sample study was designed by retrieving original metagenomic data from the GMrepo database. The differences in the distribution of the gut microbiota between CRCs and controls were analysed at the species level. A co-occurrence network was established, and the microbial interactions with environmental factors were assessed. Random forest models were used to determine significant biomarkers for differentiating CRC and control samples. Results: A total of 709 metagenomic samples from 6 projects were identified. After matching, 86 CRC patients and 86 matched healthy controls from six countries were enrolled. A total of 484 microbial species and 166 related genera were analysed. In addition to previously recognized associations between Fusobacterium nucleatum and species belonging to the genera Peptostreptococcus, Porphyromonas, and Prevotella and CRC, we found new associations with the novel species of Parvimonas micra and Collinsella tanakaei. In CRC patients, Bacteroides uniformis and Collinsella tanakaei were positively correlated with age, whereas Dorea longicatena, Adlercreutzia equolifaciens, and Eubacterium hallii had positive associations with body mass index (BMI). Finally, a random forest model was established by integrating different numbers of species with the highest model-building importance and lowest inner subcategory bias. The median value of the area under the receiver operating characteristic curve (AUC) was 0.812 in the training cohort and 0.790 in the validation set. Conclusions: Our study provides a novel bioinformatics approach for investigating the interaction between the gut microbiota and CRC using an online free database. The identification of key species and their associated genes should be further emphasized to determine the relative causality of microbial organisms in the development of CRC.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Association between the gut microbiota, inflammatory factors, and colorectal cancer: evidence from Mendelian randomization analysis
    Ma, Mingwei
    Zheng, Zicheng
    Li, Jie
    He, Yixuan
    Kang, Weiming
    Ye, Xin
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [22] Gene prediction of immune cells association between gut microbiota and colorectal cancer: a Mendelian randomization study
    Zhong, Yan
    Chen, Guanglei
    Chen, Menglu
    Cui, Junsong
    Tan, Qianren
    Xiao, Zhenghua
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [23] Metabolic Interaction Between Host and the Gut Microbiota During High-Fat Diet-Induced Colorectal Cancer
    Lee, Chaeeun
    Lee, Seungrin
    Yoo, Woongjae
    JOURNAL OF MICROBIOLOGY, 2024, 62 (03) : 153 - 165
  • [24] Combination of Metagenomics and Culture-Based Methods to Study the Interaction Between Ochratoxin A and Gut Microbiota
    Guo, Mingzhang
    Huang, Kunlun
    Chen, Siyuan
    Qi, Xiaozhe
    He, Xiaoyun
    Cheng, Wen-Hsing
    Luo, Yunbo
    Xia, Kai
    Xu, Wentao
    TOXICOLOGICAL SCIENCES, 2014, 141 (01) : 314 - 323
  • [25] Investigating the correlation between gut microbiota and prostate cancer through a two-sample Mendelian randomization analysis
    Guo, Lingyu
    An, Tian
    MEDICINE, 2025, 104 (01)
  • [26] Causal relationship between gut microbiota and differentiated thyroid cancer: a two-sample Mendelian randomization study
    Hu, Shaojun
    Tang, Chuangang
    Wang, Ling
    Feng, Fang
    Li, Xiaoxin
    Sun, Mingyu
    Yao, Lijun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Assessing the causal relationship between gut microbiota and prostate cancer: A two-sample Mendelian randomization study
    Wang, Yijie
    Long, Zhaohui
    Hong, Yulong
    Zhou, Xing
    Yang, Guang
    Tang, Cheng
    Qu, Genyi
    Li, Yuan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 190e1 - 190e10
  • [28] A case–control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race
    Tiffany L. Carson
    Doratha A. Byrd
    Kristen S. Smith
    Daniel Carter
    Maria Gomez
    Michael Abaskaron
    Rebecca B. Little
    Sh’Nese Townsend Holmes
    William J. van Der Pol
    Elliot J. Lefkowitz
    Casey D. Morrow
    Andrew D. Fruge
    Gut Pathogens, 16
  • [29] Associations Between Health Behaviors, Gastrointestinal Symptoms, and Gut Microbiota in a Cross-Sectional Sample of Cancer Survivors: Secondary Analysis from the Chemo-Gut Study
    Deleemans, Julie M.
    Chleilat, Faye
    Reimer, Raylene A.
    Lawal, Oluwaseyi A.
    Baydoun, Mohamad
    Piedalue, Katherine-Ann
    Lowry, Dana E.
    Carlson, Linda E.
    INTEGRATIVE CANCER THERAPIES, 2024, 23
  • [30] Development and evaluation of a colorectal cancer screening method using machine learning-based gut microbiota analysis
    Konishi, Yusuke
    Okumura, Shintaro
    Matsumoto, Tomonori
    Itatani, Yoshiro
    Nishiyama, Tsuyoshi
    Okazaki, Yuki
    Shibutani, Masatsune
    Ohtani, Naoko
    Nagahara, Hisashi
    Obama, Kazutaka
    Ohira, Masaichi
    Sakai, Yoshiharu
    Nagayama, Satoshi
    Hara, Eiji
    CANCER MEDICINE, 2022, 11 (16): : 3194 - 3206